New Clinical Trial for Severe GERD
GERD (gastroesophageal reflux disease) now affects nearly 65 million Americans. Also called acid reflux or heartburn, GERD occurs when stomach contents back up into the esophagus. Untreated, it can lead to Barrett’s esophagus, a dangerous precancerous condition. Most people with GERD can be effectively treated using acid-blocking medication, but nearly a third continue to have symptoms.
The LESS GERD trial will examine the effectiveness of the EndoStim Lower Esophageal Sphincter(LES) Stimulation System, a minimally invasive approach to treat severe reflux, reduce symptoms, and improve quality of life.